Frazier Life Sciences Management, L.P. Diversified Active

CIK: 0001892134 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 15, 2024

Total Value ($000): $2,137,655 (100.0% shares, 0.0% debt)

Holdings (49)

NAMS NEWAMSTERDAM PHARMA COMPANY 11.0%
Value ($000) $234,880 Shares 12,226,943 Est. Cost $10.46 Unrealized +91.8%
MIRM MIRUM PHARMACEUTICALS INC 10.4%
Value ($000) $222,077 Shares 6,495,392 Est. Cost $23.31 Unrealized +12.5%
KRYS KRYSTAL BIOTECH INC 8.5%
Value ($000) $181,521 Shares 988,460 Est. Cost $64.17 Unrealized +161.6%
HILLEVAX INC 7.2%
Value ($000) $153,523 Shares 10,617,062 Est. Cost $11.48 Unrealized
PHAT PHATHOM PHARMACEUTICALS INC 4.9%
Value ($000) $104,126 Shares 10,109,279 Est. Cost $13.68 Unrealized -24.7%
RYTM RHYTHM PHARMACEUTICALS INC 4.6%
Value ($000) $97,366 Shares 2,371,304 Est. Cost $21.21 Unrealized +88.2%
BBIO BRIDGEBIO PHARMA INC 4.3%
Value ($000) $92,014 Shares 3,632,604 Est. Cost $20.99 Unrealized +30.2%
ARQT ARCUTIS BIOTHERAPEUTICS INC 3.8%
Value ($000) $81,703 Shares 8,785,284 Est. Cost $17.08 Unrealized -47.1%
IRON DISC MEDICINE INC 3.7%
Value ($000) $79,090 Shares 1,754,834 Est. Cost $35.82 Unrealized -5.1%
PCVX VAXCYTE INC 3.7%
Value ($000) $78,485 Shares 1,039,405 Est. Cost $21.85 Unrealized +211.6%
EWTX EDGEWISE THERAPEUTICS INC 3.1%
Value ($000) $67,197 Shares 3,731,067 Est. Cost $10.16 Unrealized +71.7%
ANAB ANAPTYSBIO INC 2.5%
Value ($000) $54,270 Shares 2,165,591 Est. Cost $26.18 Unrealized -11.1%
VERONA PHARMA PLC 2.2%
Value ($000) $47,925 Shares 3,314,349 Est. Cost $14.55 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 2.0%
Value ($000) $43,443 Shares 3,687,867 Est. Cost $9.73 Unrealized +20.0%
TARS TARSUS PHARMACEUTICALS INC 2.0%
Value ($000) $43,149 Shares 1,587,527 Est. Cost $17.82 Unrealized +88.7%
RVMD REVOLUTION MEDICINES INC 1.8%
Value ($000) $38,711 Shares 997,455 Est. Cost $25.35 Unrealized +47.5%
ERAS ERASCA INC 1.8%
Value ($000) $38,270 Shares 16,216,216 Est. Cost $2.16 Unrealized 0.0%
AGIO AGIOS PHARMACEUTICALS INC 1.8%
Value ($000) $37,600 Shares 871,974 Est. Cost $29.24 Unrealized +23.4%
SLNO SOLENO THERAPEUTICS INC 1.7%
Value ($000) $35,727 Shares 875,667 Est. Cost $24.43 Unrealized +73.5%
RCKT ROCKET PHARMACEUTICALS INC 1.6%
Value ($000) $33,613 Shares 1,561,230 Est. Cost $18.73 Unrealized +22.6%
SVRA SAVARA INC 1.5%
Value ($000) $32,874 Shares 8,157,385 Est. Cost $4.02 Unrealized +10.8%
ORIC ORIC PHARMACEUTICALS INC 1.4%
Value ($000) $29,290 Shares 4,142,855 Est. Cost $8.67 Unrealized +3.2%
CGON CG ONCOLOGY INC 1.1%
Value ($000) $24,309 Shares 770,000 Est. Cost $40.84 Unrealized -15.1%
PEPG PEPGEN INC 1.1%
Value ($000) $23,984 Shares 1,502,788 Est. Cost $11.81 Unrealized +21.4%
MERUS N V 1.0%
Value ($000) $22,076 Shares 373,100 Est. Cost $25.59 Unrealized
TRVI TREVI THERAPEUTICS INC 1.0%
Value ($000) $21,996 Shares 7,381,090 Est. Cost $2.78 Unrealized -0.2%
SLN SILENCE THERAPEUTICS PLC 1.0%
Value ($000) $21,823 Shares 1,148,591 Est. Cost $19.61 Unrealized
RARE ULTRAGENYX PHARMACEUTICAL IN 0.8%
Value ($000) $17,468 Shares 425,000 Est. Cost $42.70 Unrealized 0.0%
AUTL AUTOLUS THERAPEUTICS PLC 0.8%
Value ($000) $16,089 Shares 4,623,324 Est. Cost $4.59 Unrealized
CEREVEL THERAPEUTICS HLDNG I 0.8%
Value ($000) $16,070 Shares 393,000 Est. Cost $28.54 Unrealized
MREO MEREO BIOPHARMA GROUP PLC 0.7%
Value ($000) $15,845 Shares 4,401,371 Est. Cost $3.60 Unrealized
IMTX IMMATICS N.V 0.6%
Value ($000) $13,392 Shares 1,152,456 Est. Cost $11.27 Unrealized 0.0%
TYRA TYRA BIOSCIENCES INC 0.6%
Value ($000) $13,307 Shares 832,220 Est. Cost $11.75 Unrealized +46.5%
MGNX MACROGENICS INC 0.6%
Value ($000) $12,796 Shares 3,010,727 Est. Cost $7.08 Unrealized +37.5%
APPLIED THERAPEUTICS INC 0.5%
Value ($000) $10,676 Shares 2,286,135 Est. Cost $6.49 Unrealized
PBYI PUMA BIOTECHNOLOGY INC 0.5%
Value ($000) $9,984 Shares 3,062,558 Est. Cost $5.30 Unrealized -17.2%
89BIO INC 0.4%
Value ($000) $8,010 Shares 1,000,000 Est. Cost $11.17 Unrealized
ELEVATION ONCOLOGY INC 0.4%
Value ($000) $7,988 Shares 2,958,579 Est. Cost $2.70 Unrealized
COGT COGENT BIOSCIENCES INC 0.4%
Value ($000) $7,895 Shares 936,576 Est. Cost $7.30 Unrealized +3.8%
ACAD ACADIA PHARMACEUTICALS INC 0.4%
Value ($000) $7,643 Shares 470,338 Est. Cost $17.25 Unrealized -6.4%
ARVN ARVINAS INC 0.4%
Value ($000) $7,596 Shares 285,331 Est. Cost $67.21 Unrealized -52.6%
ADVERUM BIOTECHNOLOGIES INC 0.3%
Value ($000) $7,335 Shares 1,069,244 Est. Cost $6.86 Unrealized
ALLO ALLOGENE THERAPEUTICS INC 0.3%
Value ($000) $6,682 Shares 2,867,750 Est. Cost $4.17 Unrealized -29.3%
ANTX AN2 THERAPEUTICS INC 0.2%
Value ($000) $4,491 Shares 2,088,889 Est. Cost $8.33 Unrealized -71.4%
NAMSW NEWAMSTERDAM PHARMA COMPANY 0.2%
Value ($000) $4,363 Shares 500,333 Est. Cost $0.87 Unrealized
DSGN DESIGN THERAPEUTICS INC 0.2%
Value ($000) $4,004 Shares 1,195,179 Est. Cost $3.90 Unrealized 0.0%
IMCR IMMUNOCORE HLDGS PLC 0.2%
Value ($000) $3,686 Shares 108,762 Est. Cost $33.89 Unrealized
MGX METAGENOMI INC 0.0%
Value ($000) $1,002 Shares 245,692 Est. Cost $11.50 Unrealized -40.2%
ACRS ACLARIS THERAPEUTICS INC 0.0%
Value ($000) $291 Shares 264,377 Est. Cost $13.64 Unrealized -91.4%